Seaport Res Ptn Predicts Stronger Earnings for TerrAscend

TerrAscend Corp. (OTCMKTS:TSNDF) – Investment analysts at Seaport Res Ptn boosted their FY2025 earnings estimates for TerrAscend in a research note issued on Wednesday, August 6th. Seaport Res Ptn analyst S. Randhawa now anticipates that the company will post earnings per share of ($0.10) for the year, up from their prior estimate of ($0.13). The consensus estimate for TerrAscend’s current full-year earnings is ($0.14) per share. Seaport Res Ptn also issued estimates for TerrAscend’s FY2026 earnings at ($0.09) EPS.

Separately, Atb Cap Markets raised shares of TerrAscend from a “hold” rating to a “strong-buy” rating in a report on Thursday, May 8th.

TerrAscend Price Performance

OTCMKTS:TSNDF opened at $0.55 on Monday. TerrAscend has a 52 week low of $0.23 and a 52 week high of $1.75. The firm has a market cap of $169.80 million, a price-to-earnings ratio of -1.35 and a beta of 1.39. The firm’s 50-day simple moving average is $0.34 and its 200 day simple moving average is $0.40. The company has a debt-to-equity ratio of 1.94, a quick ratio of 1.07 and a current ratio of 1.45.

TerrAscend (OTCMKTS:TSNDF) last announced its quarterly earnings results on Thursday, August 7th. The company reported ($0.03) EPS for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.01). The firm had revenue of $65.01 million during the quarter, compared to analyst estimates of $64.87 million. TerrAscend had a negative net margin of 40.86% and a negative return on equity of 23.19%.

TerrAscend Company Profile

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names.